KACTUS is excited to announce our participation in the Protein Engineering & Cell Therapy Summit (PEGS) Boston 2025—the world’s leading event for protein and cell therapy innovation. Held from May 12–16, 2025, at the Omni Boston Hotel at the Seaport, PEGS brings together global leaders in biologics, immunotherapy, oncology, and next-generation therapeutics. With 20 conference tracks and hundreds of presentations, it’s a premier platform for advancing protein science and accelerating therapeutic development.
What is the Protein Engineering & Cell Therapy Summit?
The Protein Engineering & Cell Therapy Summit (PEGS) is a globally recognized event at the forefront of therapeutic discovery. It unites top researchers, biopharma professionals, and technology developers to drive innovation in fields like antibody engineering, immunotherapy, gene editing, and machine learning. Known for its collaborative environment and scientific depth, PEGS helps shape the future of biologics by fostering exchange across critical disciplines.
Event Overview
Venue: Omni Boston Hotel at the Seaport, 450 Summer Street, Boston, MA 02210
Dates: May 12th to 16th
-
Conference Day 1: Monday, May 12, 2025 – 8:00 AM to 5:30 PM
-
Conference Day 2: Tuesday, May 13, 2025 – 8:00 AM to 5:30 PM
-
Conference Day 3: Wednesday, May 14, 2025 – 8:00 AM to 5:30 PM
-
Conference Day 4: Thursday, May 15, 2025 – 8:00 AM to 5:30 PM
-
Conference Day 5: Friday, May 16, 2025 – 8:00 AM to 12:00 PM
Booth #801
🎤 Featured Talk – Debut of Nanospheres™
Be there as our CTO, Dr. Manhee Suh, unveils the global debut of Nanospheres™ during the Next-Gen Immunotherapies track.
📅 Date: Thursday, May 15
⏰ Time: 10:15 AM
📍 Track: Next-Gen Immunotherapies
Session Title: Redefining Antigen Presentation: From Versatile MHCs for TCR Research to the Next-Gen Nanospheres™ Platform for Transmembrane Proteins
KACTUS is proud to launch Nanospheres™, a next-generation artificial membrane system making its world debut at PEGS Boston 2025. Designed to address long-standing challenges in membrane protein research, Nanospheres™ present transmembrane proteins in a highly purified, biologically relevant environment—preserving native orientation and enabling powerful applications in immunization, screening, and assay development.
This talk will also spotlight recent advances in our versatile MHC molecule formats, which streamline TCR discovery and solid tumor research, as well as our expanded GPCR portfolio available in both VLP and nanodisc formats—each engineered to deliver superior results in antibody drug discovery.
📌 Posters
🧪 GPCR VLPs & Nanodiscs for Drug Discovery
Track: C5A Difficult-to-Express Proteins
Description: GPCRs are notoriously difficult to work with due to poor expression and solubility. We’ve addressed this challenge by engineering GPCRs in both VLP and nanodisc formats. These formats support successful antibody drug discovery campaigns and enable a wide range of functional assays involving membrane proteins.
🧬 Transforming Tumor Research: Engineering MHCs as Versatile Reagents
Track: C4A Advances in Immunotherapy
Description: To overcome the limitations of adoptive T cell therapies in solid tumors, we’ve developed stable, multi-format MHC molecules with exceptional versatility. These reagents enhance TCR screening, neoantigen presentation, and tumor-targeted therapy development.
🧫 High-Performing GMP CRISPR Cas9 Protein for Cell and Gene Therapy
Track: C4B Engineering Cell Therapies
Description: Designed for clinical translation, our GMP-grade Cas9 protein exceeds 95% purity, with high activity and excellent stability. It’s been validated in T cells, Jurkat cells, and HSCs for use in CAR-T development and gene editing models like β-thalassemia.
Event Schedule
PEGS Boston offers a focused look at the tools, platforms, and strategies transforming therapeutic development. The week includes scientific sessions, poster forums, and curated networking designed to spark collaboration and accelerate discovery. Explore the full PEGS agenda for a detailed look at what’s ahead.
Monday, May 12
-
Conference Sessions: 8:00 AM – 5:30 PM
-
Exhibit Hall & Poster Viewing: 5:55 PM – 7:20 PM
-
Welcome Reception: 5:55 PM – 7:20 PM
Tuesday, May 13
-
Conference Sessions: 8:00 AM – 5:30 PM
-
Exhibit Hall & Poster Viewing: 10:35 AM – 4:40 PM
-
Coffee Break: 10:35 AM – 11:15 AM
-
Dessert Break: 1:50 PM – 2:20 PM
-
Refreshment Break: 4:00 PM – 4:40 PM
Wednesday, May 14
-
Conference Sessions: 8:00 AM – 5:30 PM
-
Exhibit Hall & Poster Viewing: 9:35 AM – 7:40 PM
-
Coffee Break: 9:35 AM – 10:20 AM
-
Ice Cream Break: 4:00 PM – 4:40 PM
-
Networking Reception: 6:40 PM – 7:40 PM
Thursday, May 15
-
Conference Sessions: 8:00 AM – 5:30 PM
-
Exhibit Hall & Poster Viewing: 10:30 AM – 1:55 PM
-
Coffee Break: 10:30 AM – 11:15 AM
-
Luncheon: 12:25 PM – 1:55 PM
Friday, May 16
-
Conference Sessions: 8:00 AM – 12:00 PM
-
Exhibit Hall: Closed
About KACTUS
KACTUS specializes in the development and production of high-quality, bioactive recombinant proteins and enzymes that support innovation across antibody drug discovery, immunotherapy, gene therapy, and mRNA therapeutics. With a catalog of over 2,500 recombinant proteins spanning diverse targets, species, tags, and formats, we are committed to meeting the evolving needs of scientists in translational research. Our focus on rigorous quality control and reliable supply ensures the consistency and performance that today’s therapeutic development demands.
Featured Products
